Autogenic embryonic stem cells established from somatic cell nuclear transfer (SCNT) embryos have been proposed as unlimited cell sources for cell transplantation-based treatment of many genetic and degenerative diseases, which can eliminate the immune rejection that occurs after transplantation. In the present study, pluripotent nuclear transfer ES (NTES) cell lines were successfully established from different strains of mice. One NTES cell line, NT1, with capacity of germline transmission, was used to investigate in vitro differentiation into cardiomyocytes. To optimize differentiation conditions for mass production of embryoid bodies (NTEBs) from NTES cells, a slow-turning lateral vessel (STLV) rotating bioreactor was used for culturing the NTES cells to produce NTEBs compared with a conventional static cultivation method. Our results demonstrated that the NTEBs formed in STLV bioreactor were more uniform in size, and no large necrotic centers with most of the cells in NTEBs were viable. Differentiation of the NTEBs formed in both the STLV bioreactor and static culture into cardiomyocytes was induced by ascorbic acid, and the results demonstrated that STLV-produced NTEBs differentiated into cardiomyocytes more efficiently. Taken together, our results suggested that STLV bioreactor provided a more ideal culture condition, which can facilitate the formation of better quality NTEBs and differentiation into cardiomyocytes more efficiently in vitro.
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Introduction
E
MBRYONIC STEM (ES) CELLS are derived from the inner cell mass of blastocyst stage preimplantation embryos (Evans and Kaufman, 1981; Martin, 1981) . ES cells can be cultured indefinitely while maintaining pluripotency and genome stability in vitro; meanwhile, all types of cells can be induced from ES cells under appropriate conditions. Based on these unique properties that ES cells possess, cell transplantation or tissue engineering-based cell therapy has been proposed to use ES cells as seed cells to treat some genetic and degenerative diseases. However, immune rejection is the major concern in applying these existing ES cell lines derived from normal fertilized embryos for therapy. Recently, two breakthrough achievements in cell reprogramming research have indicated that immune rejection occurred in cell transplantation could be overcome. ES cell lines have been successfully established from the embryos produced by somatic cell nuclear transfer (SCNT) in the mouse, and more recently, the nonhuman primate rhesus monkey (Byrne et al., 2007; Munsie et al., 2000; Orkin and Pera, 2007; Wakayama et al., 2001) . Moreover, NTES cells have been successfully induced to differentiate into hematopoietic stem cells (HSC) and transplanted into the immune-deficient mouse, which indicated that therapeutic cloning is practically feasible (Rideout et al., 2002) . More recently, mouse somatic cells have been successfully induced to pluripotent cells by transforming four transcription factors, Oct4, Sox2, C-myc, and Klf4 (Okita et al., 2007; Takahashi and Yamanaka, 2006; Wernig et al., 2007) . However, a retrovirus was used in these studies, and the safety evaluation has to be concerned to further apply this technology in human therapy. Compared to the transcription factor-induced pluripotent cells, NTES cell lines possessed more advantages in which no virus was used and the derivation efficiency was higher.
Currently, organ transplantation is the only effective treatment approach for patients suffering from severe heart failure; however, it is practically restricted by the limited organ source and immune rejection. With the development of tissue engineering, reconstruction of tissue engineered cardiac muscle from seed cells opens up a new avenue to the treatment of cardiovascular disease. ES cells are the most attractive cell sources for tissue engineering because of the unique characteristics of self-renewal and capable of differentiation into all cell types in the body (Boheler et al., 2002) . The results from a previous study have demonstrated that transplanted ES cells could form stable intracardiac grafts and survive in damaged hearts, which could improve the cardiac function in animal models (Hughes, 2002) . More recently, cardiomyocytes derived from human ES cells have been transplanted into the infarcted heart in the rat, and the results have indicated that the transplanted cardiomyocytes could partially remuscularize myocardial infarcts (Laflamme et al., 2007) . However, normal embryo-derived ES cells still cannot avoid immune response with the inevitable consequence of graft rejection in the absence of immunosuppressive therapy, and SCNT has been proposed to produce histocompatible NTES cells for cell transplantation without immune rejection in humans (Lanza et al., 1999; Srivastava and Ivey, 2006) .
In vitro differentiation of ES cells usually requires an initial aggregation step of embryoid body (EB) formation. The quality of formed EBs will affect the efficiency of cardiomyocytes differentiation dramatically. Several different methods have been developed for EB formation, such as the hanging drop technique, methylcellulose culture and static liquid suspension culture (Dang et al., 2002) . Although these approaches are useful for bioprocess development, they are unsuitable for further scale-up production. Nonetheless, standard stirred tank reactors have been successfully employed in some other studies for large-scale production of ES-derived cells (Schroeder et al., 2005) . However, conventional stirrer vessels may have the disadvantage of generating shear forces and, although manageable, these forces still can damage the cells (Chisti, 2001; Hammond and Hammond, 2001) .
Our previous studies, combined with other reports, have demonstrated that the slow-turning lateral vessel (STLV) bioreactor of the low-shear rotating cell culture systems (RCCS) facilitates the EB formation and differentiation of mouse ES cells (Gerecht-Nir et al., 2004) . It has been well established by our group and others that cardiomyocytes derived from the EBs formed in STLV displayed specific properties of functional cardiac cells (Boheler et al., 2002; E et al., 2006) . In the present study, the STLV was applied to investigate the optimal conditions for EB formation from NTES cells and further analyze the characteristics of the cadiomyocytes derived from the NTEBs (NTES cell derived embryoid body).
Materials and Methods
Establishment and culture of NTES cells
The SPF grade hybrid mice B6D2F1 (C57BL/6 ϫ DBA/2) were housed in the animal facility of the National Institute of Biological Sciences. All studies adhered to procedures consistent with the National Institute of Biological Sciences Guide for the care and use of laboratory animals.
Somatic cell nuclear transfer and derivation of NTES cells from somatic cell cloned mouse embryos were described as previous reports with minor modifications (Sung et al., 2006; Wakayama et al., 1998) . Either cumulus or sertoli cell nuclei were directly injected into enucleated B6D2F1 metaphase II (MII) oocytes and the cloned constructs were then activated in calcium-free CZB medium containing 10 mM of strontium and 5 g/mL cytochalasin B for 6 h. Cloned embryos were cultured for 86 h and the blastocysts with good morphology were selected for ES cell derivation. The protocols used for derivation of NTES cells from SCNT cloned embryos were described essentially in previous reports (Eggan et al., 2004; Hochedlinger and Jaenisch, 2002) . After removing the zona pellucida, a single-cloned blastocyst was transferred into one well of a 96-well plate and cocultured with a mitomycin C inactivated mouse embryonic fibroblast (MEF) feeder layer in the ES derivation medium containing 15% knockout serum replacement (KSR) and 50 nM MEK1 inhibitor, PD98059. After 5 days of culture, formed outgrowth of cloned blastocyst was picked up, mechanically separated, and propagated into a 24-well plate for another 4 days before passaging using trypsin-EDTA.
To maintain pluripotency of NTES cells established, the NTES cells with passage of 19-28 were cultured on MEF in the culture medium containing DMEM medium (Gibco Invitrogen, Carlsbad, CA) supplemented with 15% (v/v) fetal bovine serum (FBS), 1 mM L-glutamine, 0.1 mM mercaptoethanol, 1% nonessential amino acid stock, and 1000 U/ml LIF (all from Chemicon, Temecula, CA). The culture medium was changed daily, and the NTES cells were passaged using 0.25% trypsin and reseeded on freshly prepared feeder layers.
NTEB production in two culture systems
To optimize culture conditions for mass production of high-quality NTEBs from NTES cells, two culture strategies were compared in the present study: (1) 100-mm Petri dishes (Greiner, Frickenhausen, Germany) with 10-mL culture medium for static culture; (2) 110 mL of STLV. The NTES cells were seeded into the vessels with initial cell concentration ranging from 1 ϫ 10 3 -1 ϫ 10 7 cells/mL to find optimal concentrations. The initial rotation speed was set to 10 rpm. With the aggregation of cells, bioreactors were set to rotate at a speed in which the suspended cell aggregates remained close to a stationary point within the reactor vessel. EBs were grown in medium consisting of 80% DMEM, supplemented with 20% FBS, 100 U/mL penicillin-streptomycin, 1 mM Lglutamine, 0.1 mM ␤-mercaptoethanol, and 1% nonessential amino acid stock for 5 days. 50% of the medium was replaced by fresh medium daily.
Size determination of NTEBs
After 5 days of culture, NTEBs were sampled from the two culture systems and transferred into culture dishes; the morphology of NTEBs was analyzed using an inverted light microscope (IX70 inverted system microscopy, Olympus Optical, Melville, NY). For size analysis, the average diameter was calculated by measuring the large and small diagonals of five representative NTEBs per field in 20 fields. The results of measurements from two independent experiments are presented.
Detection of live/dead cells in NTEBs
To evaluate the quality of NTEBs formed in the two cultivation systems, acridine orange-propidium iodide (AO/PI) staining was performed to detect live/dead cells in NTEBs, and hematoxylin and eosin (HE) staining was performed to observe necrosis in the formed NTEBs. Briefly, the stock solution (AO: 670 mol/L, PI: 750 mol/L) was prepared with DMEM and kept in the dark at 4°C. Just before LÜ ET AL. 2 the experiment, 0.01 mL AO and 1.0 mL PI were mixed, diluted 10 times with DMEM and filtered. The 5-day-old NTEBs sampled from the two culture systems were incubated with AO/PI staining solution at 37°C for 10 min. Under a fluorescence microscope, live cells were stained in green, whereas dead cells were stained in red. For HE staining, NTEBs were fixed in 10% formaldehyde and embedded with paraffin. Sections were cut into 4-m thick sections, and HE staining was performed using the regular procedure.
Induction of NTES cells differentiation to cardiomyocytes
To induce differentiation of NTEBs into cardiomyocytes, 5-day-old NTEBs formed in the two culture systems were separately plated onto gelatin (0.1%)-coated 96-well plates for the evaluation of the cardiomyocyte differentiation efficiency or tissue culture dishes for immunofluorescent staining and RT-PCR assay. The culture medium used was the same as that used for EB formation, and 0.1 mg/mL ascorbic acid (Sigma, St. Louis, MO) was supplemented to induce cardiomyocyte differentiation according to a previous report (Takahashi et al., 2003) . The percentage of EBs containing beating cardiomyocytes was determined in three independent experiments after 14 days of differentiation, and the mean values Ϯ standard error of the mean (ϮSEM) were evaluated. The significance was tested by the Student's t-test.
Reverse transcription-polymerase chain reaction
To investigate the gene expression characteristics of the cardiomyocytes differentiated from NT1 ES cells, reverse transcription (RT)-PCR for GATA4, Nkx2.5, ␣-MHC, ␤-MHC, and MLC-2v was performed using standard procedures. First-strand cDNA was synthesized. The primers used for amplification of each gene were indicated in the Table 1 .
Immunofluorescence staining and confocal microscopy
To investigate expression of specific antigens in the NTESderived cardiomyocytes, immunofluorescense staining of cTnT and ␣-sarcomeric actinin was carried out. The cells were fixed in 4% paraformaldehyde in 0.1 M phosphate buffer (pH 7.4) and incubated with the primary antibody against cTnT (diluted 1:200) and ␣-sarcomeric actinin (diluted 1:200; Sigma) overnight at 4°C. FITC-labeled goat antimouse IgG was used as the secondary antibody. The cells were incubated with Hoechst33258 for genomic DNA staining and observed under a Zeiss confocal microscope with BioRad confocal software.
Statistical analysis
Effects of donor cells on the developmental potential of somatic cloned embryos and derivation of NTES cells were analyzed by a chi-square test; a probability level of p Ͻ 0.05 was considered significant.
Results
Establishment and culture of mouse NTES cells
As shown in the Table 2, 10 to 88% of SCNT cloned embryos could develop to the blastocyst stage, from which 114 NTES cell lines have been successfully established, with efficiency being from 1 to 50% in the present study. The donor cells origin and cell types used for SCNT dramatically affected the developmental potential of cloned embryos and the efficiency of NTES cell derivation. Pluripotency analysis of the NTES cell lines established was performed, and one NTES cell line, NT1, derived from the B6D2F1 cumulus cell with the capability of germ line transmission (Chang et al., unpublished) , was applied in the present study to evaluate the NTEB formation and differentiation into cardiomyocytes.
Formation of NTEBs in the rotating bioreactors
To induce embryoid bodies formation from NT1 ES cells (NTEBs), the undifferentiated NT1 ES cells were removed from the feeder layers and suspension-cultured in the two culture systems-the 110-mL STLV (Fig. 1A) and the 10-mL conventional static Petri dishes (Fig. 1B) . The cells were inoculated into the different cultures at different initial concentrations, ranging from 1 ϫ 10 3 -1 ϫ 10 7 cells/mL, to determine the optimal conditions for cell aggregation. Cell aggregation could be observed after 12 h in both cultures, depending on the initial cell density at seeding. When seeded with low cell concentrations, that is, under 1 ϫ 10 4 cells/mL, no cell aggregates were formed up to 24 h after seeding; the cells at this time point appeared dead according to Trypan blue dye exclusion assay (data not shown). At high cell inoculum, Ͼ1 ϫ 10 6 cells/mL, the cells aggregated into large clumps within hours after seeding, and increasing vessel rotation did not affect the process. Efficient cell aggregation, that is, the formation of a large number of small aggregates, was achieved in the STLV rotating vessel when seeded with 0.4-1 ϫ 10 5 cells/mL and vessel rotation speed set to 15-20 rpm. Examination under a light microscope of the STLV formed NTEBs revealed relatively homogenous small aggregates (Fig. 1C) . For comparison, NTEBs formed in the conventional static cultures showed extensive agglomeration of the NTEBs (Fig. 2D) . After 5 days of culture, NTES cells with initial cell inoculum 1 ϫ 10 5 cells/mL generated homogenous EBs in STLV with a diameter of 253 Ϯ 19 m compared with the 262 Ϯ 76 m EBs in the static cultures. Increasing the initial cell inoculum will not improve the yield of NTEBs in STLV but will increase their size. Quality evaluation of NTEBs formed in the STLV bioreactor and static culture was further performed by AO/PI and HE staining. As shown in Figure 2A , the cell viability in representative NTEBs formed in the STLV bioreactor appeared better than those formed in Petri dishes. No visible dead cells were observed in the STLV-produced NTEBs; in contrast, many dead cells stained
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Genes Primers
GATA-4 5Ј-CTC GAT ATG TTT GAT GAC TTC T-3Ј 5Ј-CGT TTT CTG GTT TGA ATC CC-3Ј Nkx2.5 5Ј-AGC AAC TTC GTG AAC TTT G-3Ј 5Ј-CCG GTC CTA GTG TGG A-3Ј ␣-MHC 5Ј-ACC GTG GAC TAC AAC AT-3Ј 5Ј-CTT TCG CTC GTT GGG A-3Ј ␤-MHC 5Ј-ACC CCT ACG ATT ATG CG-3Ј 5Ј-GTG ACG TAC TCG TTG CC-3Ј MLC-2v
5Ј-GCC AAG AAG CGG ATA GAA GG-3Ј 5Ј-CTG TGG TTC AGG GCT CAG TC-3Ј GAPDH 5Ј-AAC GAC CCC TTC ATT GAC-3Ј 5Ј-TCC ACG ACA TAC TCA GCAC-3Ј
with PI were present in the static culture-produced NTEBs (Fig. 2B) . Moreover, H&E staining ( Fig. 2C and D) further confirmed this result. Almost no necrosis could be observed in the center of NTEBs formed in the bioreactor, whereas large areas of necrosis in the NTEBs formed in Petri dishes were exhibited.
Differentiation of NTEBs to cardiomyocytes
After seeding to the dishes, NTEBs formed in STLV, and in static dishes showed different adherence capability. After 2 days of culture, almost all NTEBs formed in STLV adhered to the bottom of the dishes, whereas only 70% of EBs formed in the static dishes adhered. Moreover, after adherence, NTEBs formed in STLV extended outgrowths on the first day, and some EBs even contained beating cells on the second day. After 5 days of adherence and induction, most of the NTEBs contained beating cardiomyocyte foci (Fig. 3A) . However, the process of producing beating cells in the NTEBs formed in static dishes was delayed significantly. After 5 days of culture, the differentiated cells began to outgrow from the adherent NTEBs (Fig. 3B) . Also, the beating cells appeared earlier on the fifth to seventh day of adherence. Cardiac differentiation efficiency of NTEBs formed in both STLV and the Petri dish were compared, and the data are shown in Table 3 . Both spontaneous differentiation and ascorbic acid-induced differentiation to cardiomyocytes were compared. The results showed that the numbers of STLV-produced NTEBs containing beating cells were significantly more than those formed in the static dishes.
Expression of cardiac specific genes and antigens in the cardiomyocytes differentiated from NTES cells
The expression of cardiac specific genes in the beating cells was performed using RT-PCR. As shown in Figure 4A , all cardiac markers genes tested, such as GATA4, Nkx2.5, ␣-MHC, ␤-MHC, and MLC-2v, were exclusively expressed in the beating cells after 14 days of induction with ascorbic acid. To further investigate the expression of cardiac-specific antigens in the differentiated cardiomyocytes, immunofluorescense stainning of cTnT and ␣-sarcomeric actinin in the differentiated cardiomycytes was performed. As shown in Figure 4B , the results demonstrated that both cTnT and ␣-sarcomeric actinin were expressed in the NTES differentiated cardiomyocytes. Even the transverse striation can be clearly observed.
Discussion
The objective of present study was to evaluate the quality of NTEBs produced in STLV and static cultivation, and differentiation of NTEBs into cardiomyocytes was further investigated. We demonstrated that STLV culture can enhance the quality of NTEBs with more cells viable compared to static culture-produced NTEBs; moreover, a higher percentage of NTEBs produced in STLV can differentiate into cardiomyocytes with induction of ascorbic acid.
Therapeutic cloning is the combination of SCNT, ES cells, cell differentiation, and transplantation. Gene expression of somatic cells can be converted to the totipotent state in enucleated oocytes, and the somatic cloned embryos can develop into blastocysts with reasonable efficiency. Subsequently, ES cells can be derived from these somatic cloned embryos and the NTES cells exhibit the same genetic background as the donor somatic cells used for SCNT. Resembling the normal fertilized embryo-derived ES cells, NTES cells are pluripotent with the capacity to differentiate into all cell types both in vivo and in vitro (Brambeink et al., 2006; Li et al., 2004; Munsie et al., 2000; Wakayama et al., 2001 Wakayama et al., , 2006 . A proofof-principle experiment has proved that genetically corrected NTES cells derived from the somatic cells of an immune-deficient mouse could differentiate into HSC in vitro; moreover, transplantation of HSCs into bone marrow of the immune-deficient mouse could rescue the phenotype without immune rejection (Rideout et al., 2002) . At present, organ transplantation is the only effective treatment for patients suffering from severe heart failure; however, it is practically restricted by the organ source and immune rejection. NTES cells combined with tissue engineering might become another alternative efficient method for treatment of such a disease. However, mass production of high-quality NTEBs is the major obstacle for applying this technology. To solve this problem, we first applied the STLV bioreactor in LÜ ET AL. 4 
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culturing the germ line transmission competent NTES cells in the present study to produce NTEBs, and our results demonstrated that the NTEBs produced in STLV exhibited better quality than traditional culture protocol; moreover, the NTEBs produced could differentiate into cardiomyocytes efficiently in vitro.
RCCS were developed by NASA, in which the operating principles are as follows: (1) whole-body rotation around a horizontal axis, which is characterized by extremely low fluid shear stress, and (2) oxygenation by active or passive diffusion to the exclusion of all but dissolved gasses from the reactor chamber, yielding a vessel devoid of gas bubbles and gas/fluid interfaces (Lelkes and Unsworth, 2002) . Because the rotation speed of STLV is set very slow, the resulting flow pattern in the RCCS turns to be laminar with mild mixing. The settling of the cell clusters, which is associated with oscillations and tumbling, generates fluid mixing, and an extreme low shear environment is maintained. Another advantage of the RCCS is that they are geometrically designed so that the membrane area to volume of medium ratio is high, thus enabling efficient gas exchange. Our previous study has demonstrated that STLV culture can efficiently produce EBs from normal ES cells, and the present results further confirmed that the STLV rotation bioreactor could also provide a stable and ideal condition for the NTES cells to form NTEBs and retain good viability . To our knowledge, this is the first report comparing the effects of STLV and static suspension culture on the quality and cardiac differentiation efficacy of formed NTEBs.
By optimizing cell density and adjusting stirrer speed, the NTEBs formed in STLV have relatively uniform size compared with those produced in static suspension culture, which might indicate the quality of NTEBs formed in STLV are better. Because the ultimate goal was to generate specific ES-derived cell lineages, it was imperative to investigate if the NTEBs generated via this process were capable of differentiating into cardiomyocytes efficiently. Accordingly, cardiomyogenic induction was followed over the course of these experiments. The differentiation results showed that NTEBs formed in STLV were easy to adhere to the bottom of dishes and outgrew differentiated cells quickly. Approximately 90% of the NTEBs generated via this protocol contained vigorously contracting cells, indicating robust cardiomyogenic induction. Immunofluorescence analysis revealed that the differentiated cells have a cardiomyocyte-specific marker and transverse striation appearance. RT-PCR results demonstrated the expression of cardiac-specific genes.
It has been reported that STLV can reduce agglomeration of EBs because the aggregates are more likely to make contact with the walls of the STLV frequently (Unsworth and Lelkes, 1998; Wolf and Scharz, 1991) . Numerous contacts and collisions with the STLV wall prevented the formation of large aggregates in the STLV system, and consequently enabled the production of small-sized NTEBs with efficient cardiac differentiation ability. Numerous studies have documented cardiomyocyte formation following in vitro differentiation of mouse or human ES cells, but no investigations have ever been conducted using NTES cells. In this study, we found that cultivation of NTES cells in the STLV bioreactor enhanced the cardiomyocyte differentiation of formed NTEBs. The higher efficacy of cardiac differentiation can be explained by the good viability and the ability to attach to the bottom of the dishes.
In summary, we have successfully established an optimal system in the present study for scalable production of highquality NTEBs from the NTES cells for further differentiation toward cardiac myocytes. The produced NTEBs could differentiate into cardiomyocytes efficiently with ascorbic acid induction, which is important for the large-scale generation of NTES cell-derived cardiomyocytes for cardiac tissue engineering and cell transplantation. However, further studies need to be performed to investigate whether this system is also implacable for NTES cells derived from other species.
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